Halozyme Therapeutics Inc. and GSK have entered into a global collaboration and license agreement. Under the terms, GSK has licensed... Read more
Tag: #Global Trends
Altasciences and Certara partner to accelerate early-phase drug development
Altasciences, an integrated drug development solution company, and Certara, a global leader in model-informed drug development, have launched a strategic... Read more
Blackstone Life Sciences invests $250M in Anagram Therapeutics for Pancreatic Enzyme Replacement Therapy
Blackstone Life Sciences is making a $250 million investment in Anagram Therapeutics, a clinical-stage biopharmaceutical company. The funding is designated... Read more
Eli Lilly pledges additional $4.5B to build the largest API manufacturing site in US history
Pharmaceutical giant Eli Lilly has unveiled plans to invest an additional $4.5 billion into its Lebanon campus in Indiana. This... Read more
Novo Nordisk kicks off 2026 with a strong start led by oral obesity “Trump Card”
After a period of volatility, Danish pharmaceutical giant Novo Nordisk reported positive signals in Q1 2026. The most significant highlight... Read more
Sanofi requests to withdraw Tzield application from FDA’s controversial CNPV program
French pharmaceutical giant Sanofi has reportedly requested to remove its application for the expanded use of the diabetes drug Tzield... Read more
Pfizer scuttles $2.3B Trillium investment and exits current T-cell engager modality
Pfizer has announced a major trimming of its clinical pipeline, marked by the total collapse of its $2.3 billion Trillium... Read more
Sanofi invests $294M to scale its global AI hub in Toronto
French pharmaceutical giant Sanofi is investing $294 million to expand its global AI center of excellence in Toronto, Canada. This... Read more
Novartis to shutter German plant as part of shift toward advanced medical modalities
The Swiss pharmaceutical giant Novartis has announced plans to close its manufacturing facility in Wehr, Germany, by the end of... Read more









